Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant developments: the release of n...
“Testing, understanding and modifying the microbiome is key to addressing many diseases and improving our health. Microba’s leading technology is driving this health transformation.”
— Professor Ian Frazer, Chair of Medical Advisory Board